首页> 外国专利> PHARMACEUTICAL COMBINED PREPARATIONS CONTAINING AROMATASE INHIBITORS AND SUBSTANCES HAVING AN ESTROGEN EFFECT IN ADDITION TO THE USE THEREOF FOR PRODUCING A MEDICAMENT FOR ESTROGEN-REPLACEMENT-THERAPY

PHARMACEUTICAL COMBINED PREPARATIONS CONTAINING AROMATASE INHIBITORS AND SUBSTANCES HAVING AN ESTROGEN EFFECT IN ADDITION TO THE USE THEREOF FOR PRODUCING A MEDICAMENT FOR ESTROGEN-REPLACEMENT-THERAPY

机译:包含芳香族抑制剂和物质的具有雌激素作用的药物组合制剂,此外还用于生产用于雌激素替代治疗的药物

摘要

The invention relates to pharmaceutical combined preparations comprising aromatase inhibitors and substances having an estrogen effect, in addition to the use thereof in SERT (selective estrogen replacement therapy), particularly in menopausal problems and secondary effects thereof. Said substances having an estrogen effect are preferably combined with said estrogen, optionally, gestagens. The inventive combined preparations can be used, preferably during menopausal problems, particularly for treating and preventing postmenopausal osteoporosis and breast cancer in addition to other long-term problems which are due to a lack of estrogen.
机译:本发明涉及药物组合制剂,其除了在SERT(选择性雌激素替代疗法)中,特别是在更年期问题及其继发作用中的用途外,还包含芳香酶抑制剂和具有雌激素作用的物质。所述具有雌激素作用的物质优选与所述雌激素,任选地与孕激素结合。除了由于雌激素缺乏引起的其他长期问题之外,本发明的组合制剂可以优选在更年期问题期间使用,特别是用于治疗和预防绝经后骨质疏松症和乳腺癌。

著录项

  • 公开/公告号WO02074315A8

    专利类型

  • 公开/公告日2004-06-03

    原文格式PDF

  • 申请/专利权人 SCHERING AKTIENGESELLSCHAFT;

    申请/专利号WO2002EP02980

  • 发明设计人 ELLIESEN JOERG;

    申请日2002-03-18

  • 分类号A61K31/5685;A61K31/437;A61K31/4196;A61K31/4178;A61K31/565;A61K31/567;A61K31/569;A61K31/57;A61P15/12;

  • 国家 WO

  • 入库时间 2022-08-21 23:00:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号